Nano-X Imaging grants Attias Gali Yahav 28,283-share award

The 40,000 options vest and become exercisable in 16 equal quarterly installments, with all exercisable by May 23, 2027.

Rhea-AI Filing Summary

Nano-X Imaging Ltd. granted Chief Corporate Resources Attias Gali Yahav 28,283 ordinary shares represented by restricted share units on October 14, 2026, under its 2019 Equity Incentive Plan. The units vest in four equal semi-annual installments of 25% each on February 13, 2027, August 13, 2027, February 13, 2028, and August 13, 2028, subject to his continuous employment on each vesting date. As of October 14, 2026, he also held directly options for 6,500 ordinary shares at an exercise price of $23.86, expiring September 30, 2031; 12,500 ordinary shares at $17.63, expiring March 28, 2032; and 40,000 ordinary shares at $11.52, expiring May 23, 2033. The 6,500-share and 12,500-share options were fully vested and exercisable.

Insider Trade Summary

Grant/Award: 28,283 shares

Grant/Award 6 txns

Insider Yahav Attias Gali

Role Chief Corporate Resources

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares F1, F2	28,283	$0.00	$0.00
holding	Stock Option (right to buy ordinary shares) F3, F5	--	--	--
holding	Stock Option (right to buy ordinary shares) F3, F6	--	--	--
holding	Stock Option (right to buy ordinary shares) F3, F7	--	--	--
holding	Ordinary Shares F3	--	--	--
holding	Ordinary Shares F3, F4	--	--	--

Holdings After Transaction: Ordinary Shares — 87,757 shares (Direct); Stock Option (right to buy ordinary shares) — 59,000 contracts (Direct)

Footnotes (7)

1. F1. The transaction reported in this row consists of the grant by the Issuer's board of directors to the Reporting Person of 28,283 ordinary shares represented by 28,283 restricted share units ("RSUs"), pursuant to the Issuer's 2019 Equity Incentive Plan.
2. F2. The 28,283 RSUs reported in this row vest and settle for underlying ordinary shares in four equal semi-annual installments of 25% each following the vesting commencement date of August 13, 2026-- on February 13, 2027, August 13, 2027, February 13, 2028 and August 13, 2028-- subject, in each case, to the Reporting Person's continuous employment by the Issuer as of the applicable vesting date, such that by the two-year anniversary of the vesting commencement date (August 13, 2028), all underlying shares will be issued to the Reporting Person.
3. F3. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
4. F4. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer on February 5, 2026, of which 50% vest and settle for underlying ordinary shares on the 12-month anniversary of the grant date (February 5, 2027) and the remaining 50% on the 24-month anniversary of the grant date (February 5, 2028).
5. F5. The options reported in this row were granted to the Reporting Person by the Issuer on September 30, 2021 and are fully vested and exercisable as of the date of this report.
6. F6. The options reported in this row were granted to the Reporting Person by the Issuer on March 28, 2022 and are fully vested and exercisable as of the date of this report.
7. F7. The options reported in this row were granted to the Reporting Person by the Issuer on May 23, 2023 and vest and become exercisable in 16 equal quarterly installments of 6.25% each on each three-month anniversary of the grant date, such that all options reported in this row will be exercisable by the four-year anniversary of the grant date (May 23, 2027).

Key Figures

Restricted share units granted: 28,283 ordinary shares RSU installment: 25% Option shares and exercise price: 6,500 underlying ordinary shares at $23.86 per share +3 more

6 metrics

Restricted share units granted 28,283 ordinary shares Grant on October 14, 2026

RSU installment 25% Each of four equal semi-annual installments

Option shares and exercise price 6,500 underlying ordinary shares at $23.86 per share Options expiring September 30, 2031

Option shares and exercise price 12,500 underlying ordinary shares at $17.63 per share Options expiring March 28, 2032

Option shares and exercise price 40,000 underlying ordinary shares at $11.52 per share Options expiring May 23, 2033

Option vesting installments 16 equal quarterly installments of 6.25% 40,000 options; all exercisable by May 23, 2027

Key Terms

restricted share units, vesting commencement date, semi-annual installments, fully vested and exercisable

4 terms

restricted share units financial

"28,283 ordinary shares represented by 28,283 restricted share units"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

vesting commencement date financial

"following the vesting commencement date of August 13, 2026"

The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.

semi-annual installments financial

"four equal semi-annual installments of 25% each"

fully vested and exercisable financial

"are fully vested and exercisable as of the date of this report"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did NNOX grant Attias Gali Yahav?

Nano-X Imaging Ltd. granted Chief Corporate Resources Attias Gali Yahav 28,283 ordinary shares represented by restricted share units on October 14, 2026, under its 2019 Equity Incentive Plan.

When do the NNOX restricted share units vest?

The 28,283 restricted share units vest in four equal semi-annual installments of 25% each on February 13, 2027, August 13, 2027, February 13, 2028, and August 13, 2028. Each installment is subject to the recipient's continuous employment on the applicable vesting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/14/2026 - 04:06 PM EDT Accepted by SEC EDGAR 10/14/2026 - 04:05 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Yahav Attias Gali

(Last) (First) (Middle)

C/O NANO-X IMAGING LTD., OFER TECH PARK

94 SHLOMO SHMELTZER ROAD

(Street)

PETACH TIKVA 4970602

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Nano-X Imaging Ltd. [ NNOX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Corporate Resources

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	10/14/2026		A(1)		28,283	A	$0	28,283(2)	D
Ordinary Shares(3)								20,000	D
Ordinary Shares(3)								39,474(4)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy ordinary shares)(3)	$23.86							(5)	09/30/2031	Ordinary shares	6,500		6,500	D
Stock Option (right to buy ordinary shares)(3)	$17.63							(6)	03/28/2032	Ordinary shares	12,500		12,500	D
Stock Option (right to buy ordinary shares)(3)	$11.52							(7)	05/23/2033	Ordinary shares	40,000		40,000	D

Explanation of Responses:

1. The transaction reported in this row consists of the grant by the Issuer's board of directors to the Reporting Person of 28,283 ordinary shares represented by 28,283 restricted share units ("RSUs"), pursuant to the Issuer's 2019 Equity Incentive Plan.

2. The 28,283 RSUs reported in this row vest and settle for underlying ordinary shares in four equal semi-annual installments of 25% each following the vesting commencement date of August 13, 2026-- on February 13, 2027, August 13, 2027, February 13, 2028 and August 13, 2028-- subject, in each case, to the Reporting Person's continuous employment by the Issuer as of the applicable vesting date, such that by the two-year anniversary of the vesting commencement date (August 13, 2028), all underlying shares will be issued to the Reporting Person.

3. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.

4. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer on February 5, 2026, of which 50% vest and settle for underlying ordinary shares on the 12-month anniversary of the grant date (February 5, 2027) and the remaining 50% on the 24-month anniversary of the grant date (February 5, 2028).

5. The options reported in this row were granted to the Reporting Person by the Issuer on September 30, 2021 and are fully vested and exercisable as of the date of this report.

6. The options reported in this row were granted to the Reporting Person by the Issuer on March 28, 2022 and are fully vested and exercisable as of the date of this report.

7. The options reported in this row were granted to the Reporting Person by the Issuer on May 23, 2023 and vest and become exercisable in 16 equal quarterly installments of 6.25% each on each three-month anniversary of the grant date, such that all options reported in this row will be exercisable by the four-year anniversary of the grant date (May 23, 2027).

Remarks:

Exhibit 24.1 - Power of Attorney

	/s/ Marina Gofman Feler, attorney-in-fact	10/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)